Daniel Sommermeyer

CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Journal of Clinical Investigation · 2016 · 2.1K citations · Full text

Medicine, Immunology, Oncology +17

Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

Daniel Sommermeyer, Michael Hudecek, Paula L. Kosasih et al. · Leukemia · 2015 · 861 citations

Life Sciences, Immunology, Oncology +16

Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells

Michael Hudecek, Maria Teresa Lupo Stanghellini, Paula L. Kosasih et al. · Clinical Cancer Research · 2013 · 540 citations · Full text

Life Sciences, Immunology, Oncology +17

The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity

Michael Hudecek, Daniel Sommermeyer, Paula L. Kosasih et al. · Cancer Immunology Research · 2014 · 523 citations · Full text

Life Sciences, Immunology, Oncology +17

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function

Alexander I. Salter, Richard G. Ivey, Jacob J. Kennedy et al. · Science Signaling · 2018 · 499 citations

Life Sciences, Cell Biology, Immunology +17